Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
94 hedge funds and large institutions have $382M invested in Calithera Biosciences, Inc in 2017 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 35 increasing their positions, 13 reducing their positions, and 17 closing their positions.
169% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 13
124% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 17
69% more capital invested
Capital invested by funds: $226M → $382M (+$157M)
27% more funds holding
Funds holding: 74 → 94 (+20)
60% less call options, than puts
Call options by funds: $1.22M | Put options by funds: $3.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$23.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$17.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.8M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.12M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
+$5.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$8.37M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$4.63M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.03M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.46M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$1.15M |
CALA Hedge Fund Activity: Q2 2017 in Review
94 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2017, worth a combined $382M — up 69% from $226M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new CALA positions and 17 closed out — a net gain of 21 holders — while 35 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $23.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $8.37M sold.
- 94 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2017, up from 74 in Q1 2017.
- Funds reported $382M of Calithera Biosciences, Inc stock for Q2 2017, up 69% quarter-over-quarter.
- 38 funds opened new Calithera Biosciences, Inc positions in Q2 2017 and 17 closed out, a net change of +21 holders.
- The largest Calithera Biosciences, Inc buyer in Q2 2017 was BlackRock, an estimated $23.5M added.
- The largest Calithera Biosciences, Inc seller in Q2 2017 was RA Capital Management, an estimated $8.37M sold.
Based on aggregated 13F filings for Q2 2017.